Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
ECM enrichment restores the morphology and functionality of Müller Glial Cells in the rd1 Model of Retinitis Pigmentosa
Author Affiliations & Notes
  • Harmonie Vallese-Maurizi
    INIBIBB, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Buenos Aires, Argentina
  • Solange Viera
    INIBIBB, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Buenos Aires, Argentina
  • Georgina Coló
    INIBIBB, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Buenos Aires, Argentina
  • Olga Lorena German
    INIBIBB, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Buenos Aires, Buenos Aires, Argentina
  • Footnotes
    Commercial Relationships   Harmonie Vallese-Maurizi None; Solange Viera None; Georgina Coló None; Olga German None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1663. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Harmonie Vallese-Maurizi, Solange Viera, Georgina Coló, Olga Lorena German; ECM enrichment restores the morphology and functionality of Müller Glial Cells in the rd1 Model of Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1663.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In Retinitis Pigmentosa the progressive loss of photoreceptors (PRs) leads to vision impairment. Our previous work showed that Müller glial cells (MGCs), specialized retinal cells that support PRs survival, are affected in the retinal degeneration mouse model (rd1). Even before PRs degeneration, rd1 MGCs evidence a reduced regenerative potential, incapacity to form lamellipodia and impairment of their neuroprotective role on PRs. Whether the extracellular matrix (ECM) is affected in rd1 retinas, altering MGCs adhesion and functionality and contributing to PRs death remains unclear. The aim of this study was to investigate ECM protein expression in rd1 retinas prior to the peak of PRs degeneration and assess whether ECM pretreatment can restore the morphology and functionality of rd1 MGCs in vitro.

Methods : Mixed neuron-glial cultures were prepared from postnatal day 2 rd1 and wt mouse retinas. We analyzed SPARC and Fibronectin expression (ECM proteins), Paxillin (focal adhesions, FAs), and actin by immunocytochemistry, and measured the neuron-glial cluster area with Image J software. We obtained ECM (SPARC)-enriched conditioned media (CM) from retinoblastoma RN22 cell line cultures. We then grew rd1 cultures on dishes pre-treated or not with ECM-CM to evaluate its effects on neuron-glial cluster area, FAs, actin cytoskeleton, cell proliferation, measured through BrdU nucleotide incorporation, and cell death, assessed by DAPI staining.

Results : Neuron-glial clusters were smaller, whereas expression of SPARC was significantly lower (p=0.0059) and that of fibrillary fibronectin higher in rd1 than in wt neuron-glial cultures (p=0.0002). Rd1 MGCs had shorter FA (p= 0.0059), which showed mainly a cortical distribution (p=0.001), contrary to wt MGCs. Actin displayed a cortical distribution, and higher fluorescence intensity (p= 0.004) in rd1 compared to wt cultures. Noteworthy, dish pre-treatment with ECM-CM increased the size of neuron-glial clusters (p= 0.0006), restored the distribution of glial FAs, and reduced phalloidin fluorescence intensity (p= 0.0005). Moreover, ECM-CM pre-treatment also stimulated MGCs proliferation (p= 0.021) and increased PRs survival (p= 0.0003) in rd1 cultures.

Conclusions : Our results suggest that expression of ECM proteins and FAs assembly are altered in rd1 MGCs and enrichment with ECM restores MGCs functionality, contributing to PRs survival.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×